{"id":23995,"date":"2020-09-17T00:00:00","date_gmt":"2020-09-17T04:00:00","guid":{"rendered":"https:\/\/www.cancerresearch.org\/media-room\/2020\/cri-goes-virtual-immunotherapy-patient-summit\/"},"modified":"2022-09-12T14:02:45","modified_gmt":"2022-09-12T18:02:45","slug":"cri-goes-virtual-immunotherapy-patient-summit","status":"publish","type":"cri_news","link":"https:\/\/www.cancerresearch.org\/es\/media-room\/cri-goes-virtual-immunotherapy-patient-summit","title":{"rendered":"Las conferencias para pacientes de inmunoterapia del Cancer Research Institute ser\u00e1n virtuales y conectar\u00e1n a pacientes y cuidadores con los principales expertos en inmunoterapia contra el c\u00e1ncer\ufffc"},"content":{"rendered":"\n<p>NUEVA YORK, 17 de septiembre de 2020 \u2013 El Cancer Research Institute (CRI), organizaci\u00f3n sin fines de lucro consagrada a aprovechar la capacidad de nuestro sistema inmunitario para controlar y potencialmente curar todos los tipos de c\u00e1ncer, llevar\u00e1 a cabo su&nbsp;<a href=\"https:\/\/www.cancerresearch.org\/virtual%20-immunotherapy-patient-summit\">Conferencia 2020 para pacientes de inmunoterapia<\/a>&nbsp;en forma virtual y gratuita el 2 y 3 de octubre de 2020, para educar y capacitar a la comunidad del c\u00e1ncer sobre la inmunoterapia y los ensayos cl\u00ednicos. El galardonado presentador de televisi\u00f3n, periodista, productor ejecutivo y fil\u00e1ntropo&nbsp;Tamron Hall ser\u00e1 el moderador del evento de dos d\u00edas.<\/p>\n\n\n\n<p>\u00abContinuando con el \u00e9xito de las conferencias presenciales, ofrecemos ahora una plataforma interactiva en l\u00ednea que permite a miles de pacientes y cuidadores entrar en contacto con los expertos en inmunoterapia que est\u00e1n a la vanguardia de los hallazgos y avances cient\u00edficos, todo desde la comodidad y seguridad de su hogar y sin costo\u00bb, explic\u00f3 Jill O\u2019Donnell-Tormey, Ph. D., Directora Ejecutiva y de Asuntos Cient\u00edficos del CRI.<\/p>\n\n\n\n<p>El programa se dividir\u00e1 en dos partes: el viernes 2 de octubre de 12:00 p. m. a 2:00 p. m. EDT, y el s\u00e1bado 3 de octubre de 12:00 p. m. a 3:00 p. m. EDT. La conferencia virtual para pacientes de inmunoterapia es una oportunidad \u00fanica para que los pacientes con c\u00e1ncer y sus cuidadores puedan:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li><strong>Escuchar a destacados m\u00e9dicos<\/strong>&nbsp;con experiencia en inmunoterapia contra el c\u00e1ncer, as\u00ed como a pacientes tratados con inmunoterapia, e interactuar con ellos;<\/li><li><strong>Recibir informaci\u00f3n valiosa sobre los ensayos cl\u00ednicos<\/strong>&nbsp;para saber si pueden ser una buena opci\u00f3n de tratamiento;<\/li><li><strong>Sumarse a los grupos de debate dirigidos por expertos<\/strong>&nbsp;donde se analizan determinados tipos de c\u00e1ncer, para conocer los \u00faltimos avances y descubrimientos en materia de tratamientos.<\/li><\/ul>\n\n\n\n<p>Como beneficio adicional, quienes asistan al evento virtual podr\u00e1n optar por recibir una consulta individual gratuita y confidencial con un asesor de ensayos cl\u00ednicos del CRI, quien podr\u00e1 ayudarlos a identificar los ensayos cl\u00ednicos de inmunoterapia espec\u00edficos para un diagn\u00f3stico, historial de tratamiento y circunstancias particulares.<\/p>\n\n\n\n<p><strong>Inscr\u00edbase en&nbsp;<a href=\"https:\/\/www.cancerresearch.org\/patient-summits\">cancerresearch.org\/virtualsummit<\/a>.<\/strong><\/p>\n\n\n\n<p>D\u00eda 1 &#8211; Temas y oradores:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Inmunoterapia 101: Conceptos b\u00e1sicos y m\u00e1s<ul><li>E. John Wherry, Ph. D., Universidad de Pensilvania<\/li><li><em>Preguntas y respuestas en vivo. Moderador: Tamron Hall<\/em><\/li><\/ul><\/li><li>Ensayos cl\u00ednicos de inmunoterapia<ul><li>Dr. Ezra Cohen, Centro M\u00e9dico de San Diego, Universidad de California<\/li><\/ul><\/li><li>Perspectivas del paciente de inmunoterapia<ul><li>Stephen Estrada, antiguo paciente de c\u00e1ncer colorrectal<\/li><li>Alan Kaufman, antiguo paciente con melanoma<\/li><li>Karen Peterson, antigua paciente de c\u00e1ncer de mama<\/li><li><em>Preguntas y respuestas en vivo. Moderador: Dr. Ezra Cohen<\/em><\/li><\/ul><\/li><\/ul>\n\n\n\n<p>D\u00eda 2 &#8211; Sesiones grupales y oradores:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>El c\u00e1ncer de mama y la inmunoterapia<ul><li>Dra. Sylvia Adams y Victor Ty, enfermero registrado, Centro Oncol\u00f3gico Perlmutter del Centro M\u00e9dico Langone de la Universidad de Nueva York<\/li><\/ul><\/li><li>El c\u00e1ncer de ovario y la inmunoterapia<ul><li>Dr. Kunle Odunsi, Ph. D., Centro Oncol\u00f3gico Roswell Park<\/li><\/ul><\/li><li>El c\u00e1ncer de pr\u00f3stata y la inmunoterapia<ul><li>Dr. Sumit Subudhi, Ph. D., Centro Oncol\u00f3gico MD Anderson, Universidad de Texas<\/li><\/ul><\/li><li>El c\u00e1ncer de pulm\u00f3n y la inmunoterapia<ul><li>Dra. Leena Gandhi, Ph. D., Instituto del C\u00e1ncer Dana-Farber<\/li><\/ul><\/li><li>El melanoma y la inmunoterapia<ul><li>Dr. Jedd Wolchok, Ph. D. Memorial Sloan Kettering Cancer Center<\/li><\/ul><\/li><\/ul>\n\n\n\n<p>La Conferencia virtual 2020 del CRI para pacientes de inmunoterapia se lleva a cabo con el generoso apoyo de las siguientes empresas e instituciones:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Patrocinadores<br>Oro: Bristol Myers Squibb<br>Plata: Merck&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br>Bronce: AstraZeneca<\/li><li>Colaboradores<br>Exelixis, Genentech, GSK, Lilly Oncology, Nektar, Regeneron, Sanofi Genzyme<\/li><li>Amigos<br>Foundation Medicine, Novartis, Pfizer<\/li><li>Instituciones organizadoras<br>Centro Oncol\u00f3gico MD Anderson, Centro M\u00e9dico Langone de la Universidad de Nueva York, Centro Oncol\u00f3gico Roswell Park, Centro Oncol\u00f3gico Moores de San Diego, Universidad de California<\/li><\/ul>\n\n\n\n<p><strong>Contacto del evento<\/strong><br>Caroline Offit,&nbsp;<a href=\"mailto:patients@cancerresearch.org\">patients@cancerresearch.org<\/a><\/p>\n\n\n\n<p><strong>Contacto con los medios<\/strong><br>Brian M. Brewer, +212.688.7515 x242,&nbsp;<a href=\"mailto:bbrewer@cancerresearch.org\">bbrewer@cancerresearch.org<\/a><\/p>\n\n\n\n\n\n<p><strong>Acerca de la<\/strong>&nbsp;<strong>Serie de conferencias del CRI sobre inmunoterapia para pacientes<\/strong><\/p>\n\n\n\n<p>Las&nbsp;<a href=\"https:\/\/www.cancerresearch.org\/patient-summits\">Conferencias para pacientes de inmunoterapia<\/a>&nbsp;del Cancer Research Institute son&nbsp;eventos gratuitos, en l\u00ednea o presenciales, que conectan a los pacientes de c\u00e1ncer y sus cuidadores con expertos m\u00e9dicos y cient\u00edficos para conocer los nuevos avances en la inmunoterapia como tratamiento del c\u00e1ncer. Desde 2016, el CRI ha llevado a cabo casi 20 conferencias en los Estados Unidos. Siga el evento en las redes sociales con el hashtag #CRIsummit.<\/p>\n\n\n\n<p><strong>Acerca del<\/strong>&nbsp;<strong>Cancer Research Institute<\/strong><\/p>\n\n\n\n<p>El Cancer Research Institute (CRI), fundado en 1953, es una organizaci\u00f3n estadounidense sin fines de lucro y muy bien valorada, consagrada exclusivamente a salvar vidas al promover el descubrimiento y desarrollo de inmunoterapias eficaces para todos los tipos de c\u00e1ncer. Asesorado por un Consejo Asesor Cient\u00edfico de renombre mundial, que incluye a cuatro premios Nobel y 26 miembros de la Academia Nacional de Ciencias, el CRI ha invertido 445 millones de d\u00f3lares para apoyar la investigaci\u00f3n que realizan los inmun\u00f3logos e inmun\u00f3logos tumorales de los centros m\u00e9dicos y universidades m\u00e1s destacados del mundo. Asimismo, el CRI ha contribuido a lograr muchos de los principales avances cient\u00edficos que demuestran el potencial de la inmunoterapia para cambiar la manera de tratar el c\u00e1ncer. Para obtener m\u00e1s informaci\u00f3n, visite el sitio&nbsp;<a href=\"https:\/\/www.cancerresearch.org\/\">cancerresearch.org<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cancer Research Institute goes virtual for its Immunotherapy Patient Summit Series,<br \/>\nconnecting patients and caregivers with leading experts in cancer immunotherapy.<\/p>\n","protected":false},"featured_media":14870,"template":"","tags":[391,424],"resource_cancer_types":[],"resource_patient_age":[],"resource_cancer_stage":[],"resource_treatment_type":[],"resource_treatment_status":[],"class_list":["post-23995","cri_news","type-cri_news","status-publish","has-post-thumbnail","hentry","tag-patient-education-es","tag-patient-summits-es"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Immunotherapy Patient Summit Goes Virtual<\/title>\n<meta name=\"description\" content=\"Cancer Research Institute goes virtual for its Immunotherapy Patient Summit Series, connecting patients and caregivers with leading experts in cancer immunotherapy.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/media-room\/cri-goes-virtual-immunotherapy-patient-summit\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Immunotherapy Patient Summit Goes Virtual\" \/>\n<meta property=\"og:description\" content=\"Cancer Research Institute goes virtual for its Immunotherapy Patient Summit Series, connecting patients and caregivers with leading experts in cancer immunotherapy.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/media-room\/cri-goes-virtual-immunotherapy-patient-summit\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2022-09-12T18:02:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/ebd09d2a-8519-4f41-8f1d-29465a2218a0.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Immunotherapy Patient Summit Goes Virtual\" \/>\n<meta name=\"twitter:description\" content=\"Cancer Research Institute goes virtual for its Immunotherapy Patient Summit Series, connecting patients and caregivers with leading experts in cancer immunotherapy.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/ebd09d2a-8519-4f41-8f1d-29465a2218a0.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/media-room\/cri-goes-virtual-immunotherapy-patient-summit\",\"url\":\"https:\/\/www.cancerresearch.org\/media-room\/cri-goes-virtual-immunotherapy-patient-summit\",\"name\":\"Immunotherapy Patient Summit Goes Virtual\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/media-room\/cri-goes-virtual-immunotherapy-patient-summit#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/media-room\/cri-goes-virtual-immunotherapy-patient-summit#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/9d07bc72-d99c-4bbf-ba18-3b2bee984f97.jpg\",\"datePublished\":\"2020-09-17T04:00:00+00:00\",\"dateModified\":\"2022-09-12T18:02:45+00:00\",\"description\":\"Cancer Research Institute goes virtual for its Immunotherapy Patient Summit Series, connecting patients and caregivers with leading experts in cancer immunotherapy.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/media-room\/cri-goes-virtual-immunotherapy-patient-summit#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/media-room\/cri-goes-virtual-immunotherapy-patient-summit\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/media-room\/cri-goes-virtual-immunotherapy-patient-summit#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/9d07bc72-d99c-4bbf-ba18-3b2bee984f97.jpg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/9d07bc72-d99c-4bbf-ba18-3b2bee984f97.jpg\",\"width\":700,\"height\":500},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/media-room\/cri-goes-virtual-immunotherapy-patient-summit#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Media Room Article\",\"item\":\"https:\/\/www.cancerresearch.org\/media-room\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Las conferencias para pacientes de inmunoterapia del Cancer Research Institute ser\u00e1n virtuales y conectar\u00e1n a pacientes y cuidadores con los principales expertos en inmunoterapia contra el c\u00e1ncer\ufffc\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Immunotherapy Patient Summit Goes Virtual","description":"Cancer Research Institute goes virtual for its Immunotherapy Patient Summit Series, connecting patients and caregivers with leading experts in cancer immunotherapy.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/media-room\/cri-goes-virtual-immunotherapy-patient-summit","og_locale":"es_ES","og_type":"article","og_title":"Immunotherapy Patient Summit Goes Virtual","og_description":"Cancer Research Institute goes virtual for its Immunotherapy Patient Summit Series, connecting patients and caregivers with leading experts in cancer immunotherapy.","og_url":"https:\/\/www.cancerresearch.org\/media-room\/cri-goes-virtual-immunotherapy-patient-summit","og_site_name":"Cancer Research Institute","article_modified_time":"2022-09-12T18:02:45+00:00","og_image":[{"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/ebd09d2a-8519-4f41-8f1d-29465a2218a0.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_title":"Immunotherapy Patient Summit Goes Virtual","twitter_description":"Cancer Research Institute goes virtual for its Immunotherapy Patient Summit Series, connecting patients and caregivers with leading experts in cancer immunotherapy.","twitter_image":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/ebd09d2a-8519-4f41-8f1d-29465a2218a0.jpg","twitter_misc":{"Tiempo de lectura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/media-room\/cri-goes-virtual-immunotherapy-patient-summit","url":"https:\/\/www.cancerresearch.org\/media-room\/cri-goes-virtual-immunotherapy-patient-summit","name":"Immunotherapy Patient Summit Goes Virtual","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/media-room\/cri-goes-virtual-immunotherapy-patient-summit#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/media-room\/cri-goes-virtual-immunotherapy-patient-summit#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/9d07bc72-d99c-4bbf-ba18-3b2bee984f97.jpg","datePublished":"2020-09-17T04:00:00+00:00","dateModified":"2022-09-12T18:02:45+00:00","description":"Cancer Research Institute goes virtual for its Immunotherapy Patient Summit Series, connecting patients and caregivers with leading experts in cancer immunotherapy.","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/media-room\/cri-goes-virtual-immunotherapy-patient-summit#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/media-room\/cri-goes-virtual-immunotherapy-patient-summit"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/media-room\/cri-goes-virtual-immunotherapy-patient-summit#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/9d07bc72-d99c-4bbf-ba18-3b2bee984f97.jpg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/9d07bc72-d99c-4bbf-ba18-3b2bee984f97.jpg","width":700,"height":500},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/media-room\/cri-goes-virtual-immunotherapy-patient-summit#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Media Room Article","item":"https:\/\/www.cancerresearch.org\/media-room"},{"@type":"ListItem","position":3,"name":"Las conferencias para pacientes de inmunoterapia del Cancer Research Institute ser\u00e1n virtuales y conectar\u00e1n a pacientes y cuidadores con los principales expertos en inmunoterapia contra el c\u00e1ncer\ufffc"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_news\/23995","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_news"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/14870"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=23995"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/tags?post=23995"},{"taxonomy":"resource_cancer_types","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_types?post=23995"},{"taxonomy":"resource_patient_age","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_patient_age?post=23995"},{"taxonomy":"resource_cancer_stage","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_stage?post=23995"},{"taxonomy":"resource_treatment_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_type?post=23995"},{"taxonomy":"resource_treatment_status","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_status?post=23995"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}